BEYORLI Trademark

Trademark Overview

On Friday, September 5, 2025, a trademark application was filed for BEYORLI with the United States Patent and Trademark Office. The USPTO has given the BEYORLI trademark a serial number of 99376159. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Friday, January 16, 2026. This trademark is owned by Glaxo Group Limited. The BEYORLI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives
beyorli

General Information

Serial Number99376159
Word MarkBEYORLI
Filing DateFriday, September 5, 2025
Status653 - SUSPENSION LETTER - MAILED
Status DateFriday, January 16, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 5, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type77 - NOT AVAILABLE
AddressStevenage SG12NY
GB

Trademark Events

Event DateEvent Description
Friday, September 5, 2025NEW APPLICATION ENTERED
Friday, September 5, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 5, 2025APPLICATION FILING RECEIPT MAILED
Friday, January 16, 2026ASSIGNED TO EXAMINER
Friday, January 16, 2026SUSPENSION LETTER WRITTEN
Friday, January 16, 2026LETTER OF SUSPENSION E-MAILED
Friday, January 16, 2026NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Related Keywords

beyorli pharmaceutical preparations diseases infectious treatment dermatological psychiatric gastrointestinal neurological respiratory